← all drugs
Caspofungin Acetate Injection
being discontinued · Anti-Infective · Snapshot: 2026-10-09
- Manufacturers listed
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.), Fresenius Kabi USA, LLC
- Machine-readable
- JSON for this drug
Presentations (3)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 06/30/2026 |
| Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 06/30/2026 |
| Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10) | Fresenius Kabi USA, LLC | unknown | 01/12/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.